9th Annual Biomarkers Congress

Immunology: University of Chicago

Total Score People Score Events Score
20 15 9
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Innate Immune Sensing in the Tumor Microenvironment Chairperson: Thomas Frank Gajewski, University of Chicago, Chicago, IL Thomas F Gajewski
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Thomas F Gajewski
Cancer Methylomes for Biomarker and Pathway Discovery Chairperson: Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo, Japan Chuan He
April 12, 2011 New Insights into Normal versus Dysregulated B Cell Function (D6) The Regulatory and Molecular Logic of IL-7R and pre-BCR Signaling in B Cell Development Harinder Singh
The Human B Cell Response to Annual and H1N1 Influenza Virus Patrick C. Wilson
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) IL-15, a Checkpoint in Tissue Immunity Bana Jabri
Mucosal Biology (X5) | Short Talk: Co-Adjuvant Effects of Retinoic Acid and IL-15 Induce Inflammatory Immunity to Dietary Antigens Valerie Abadie
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) IL-15, a Checkpoint in Tissue Immunity Bana Jabri
Regulation of Anti-Microbial Peptides and IL-17 by TLR1 during Oral Yersinia Enterocolitica Infection R William DePaolo
Workshop 4: Epithelial Barrier Function and Bugs Bana Jabri
Genetic and Molecular Basis of Intestinal Inflammation and Allergy | Short Talk: Co-Adjuvant Effects of Retinoic Acid and IL-15 Induce Inflammatory Immunity to Dietary Antigens Valerie Abadie
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Obesity (J2) | Stranger in a Strange Land: Glycogen Metabolism in Adipose Tissue Matthew Brady
January 12, 2011 Obesity (J2) Adipose Tissue Architecture | Stranger in a Strange Land: Glycogen Metabolism in Adipose Tissue Matthew Brady
January 9, 2011 NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses (A4) IL-15: A Checkpoint in Tissue Immunity | Colorado Ballroom Bana Jabri
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Title: TBD : Track 3-1 Harinder Singh
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
clinical trials-- Grant Writing Workshop Richard L Schilsky
developmental therapeutics-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
genitourinary cancer-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
leukemia, myelodysplasia, and transplantation-- Advances in Acute Leukemia Therapy Wendy Stock
lung cancer-- New Developments in Management of Malignant Mesothelioma Hedy L. Kindler
lung cancer-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Everett E Vokes
melanoma/skin cancers-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
tumor biology-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
tumor biology-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
meet the professor sessions-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Everett E Vokes
clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.